Targeting the hERG1/β1 integrin complex in lipid rafts potentiates statins anti-cancer activity in pancreatic cancer
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.A novel therapeutic strategy targeting the hERG1 potassium channel and integrin β1 complex in pancreatic cancer shows promise. Combining statins with a specific antibody significantly inhibits cancer cell growth and migration, offering a potential new treatment for PDAC.
Area Of Science
- Oncology
- Molecular Cell Biology
- Pharmacology
Background
- Plasma membrane macromolecular complexes act as signaling hubs crucial for cell behavior, especially in cancer.
- The hERG1 potassium channel and integrin β1 receptor complex localizes in Lipid Rafts (LRs) in Pancreatic Ductal Adenocarcinoma (PDAC).
Purpose Of The Study
- To investigate the role of the hERG1/integrin β1 complex in PDAC signaling and explore therapeutic strategies targeting this complex.
- To evaluate the efficacy of combining statins and a bispecific antibody (scDb-hERG1-β1) in preclinical models of PDAC.
Main Methods
- Localization of the hERG1/integrin β1 complex in LRs of PDAC cells.
- Analysis of downstream signaling pathways involving PI3K/Akt, cyclins, p21, Rac-1, and f-actin.
- In vitro and in vivo studies using methyl-beta-cyclodextrin (MβCD), statins, scDb-hERG1-β1, and chemotherapeutic drugs.
Main Results
- The hERG1/integrin β1 complex activates PI3K/Akt signaling, promoting PDAC cell proliferation and migration.
- Disrupting LRs with MβCD or inhibiting cholesterol synthesis with statins, alone or combined with scDb-hERG1-β1, inhibits PDAC cell growth and motility.
- Combination therapy with statins and scDb-hERG1-β1 demonstrated synergistic anti-neoplastic effects, enhanced sensitivity to chemotherapy, reduced tumor growth, and improved survival in vivo.
Conclusions
- The hERG1/integrin β1 complex in LRs is a key driver of PDAC progression.
- Targeting this complex with statins and scDb-hERG1-β1 offers a promising novel therapeutic strategy for PDAC patients.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...